What Cereal Can Teach Us About the Generic Drug Market
Washington Times | Sally C. Pipes
January 2, 2022
Imagine you’re walking the aisles of your local supermarket, on the hunt for your favorite cereal. You usually purchase the generic version, since it tastes nearly the same and is much cheaper than the name-brand version.
Read more. . . |
|
The FDA Needs Reform. Biden's Nominee is Not the Person to Do It
Washington Examiner | Henry I. Miller, M.S., M.D. and Jeff Stier
December 29, 2021
. . . The FDA, a huge and critically important but dysfunctional organization, now needs a bold, clear-thinking reformer, but Califf, the ultimate insider, has the ideal resume to keep it on the wrong path. |
|
Expanding Telehealth Access is a Lifesaver for Vulnerable Patients
Palm Beach Post, Cincinnati Enquirer and Yahoo! News | Sally C. Pipes
December 29, 2021
It’s hard to find a silver lining in a pandemic. But COVID-19 has convinced the medical and policymaking establishments, perhaps unwittingly, that high-quality care can be delivered remotely. The telehealth revolution is upon us. |
|
Democrats Stumble Over Their Shady BBB Gimmicks
Newsmax | Sally C. Pipes
December 29, 2021
Last week, on Dec. 19 specifically, Sen. Joe Manchin, D-W.Va., announced that he would not support the current iteration of the Build Back Better Act. His decision calls the future of the $1.75 trillion spending package into serious question. For this, Democrats have only themselves to blame.
Read more. . . |
|
|
|
